Clinical Trial Update: Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated autologous mesenchymal stem cell transplantation in decompensated cirrhosis patients treated with pioglitazone; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Royan Institute | Conditions: Liver Fibrosis | Phase 1 | Status: COMPLETED